MediWound Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	20.93	20.22	18.69	26.5	23.76	21.76
Revenue Growth (YoY)	6.15%	8.22%	-29.48%	11.50%	9.19%	-31.54%
Cost of Revenue	17.05	17.59	15.11	13.33	14.99	14.22
Gross Profit	3.88	2.63	3.58	13.17	8.77	7.55
Selling, General & Admin	14.6	13.14	11.61	10.65	9.74	8.69
Research & Development	12.83	8.88	7.47	10.18	10.26	7.7
Other Operating Expenses	0.02	0.02	-	-	-	-
Operating Expenses	27.45	22.03	19.08	20.83	19.99	16.39
Operating Income	-23.57	-19.4	-15.5	-7.66	-11.22	-8.84
Interest Expense	-	-0.53	-0.27	-0.1	-0.12	-0.83
Interest & Investment Income	15.36	2.05	2.34	0.27	0.01	0.3
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.65	0.06	-0.51	0.11
Other Non Operating Income (Expenses)	-12.26	-12.26	-0.96	-11.4	-0.19	-0.45
EBT Excluding Unusual Items	-20.49	-30.16	-15.05	-18.84	-12.03	-9.71
Other Unusual Items	-	-	8.52	-0.68	-1.49	0.43
Pretax Income	-20.49	-30.16	-6.53	-19.52	-13.52	-9.28
Income Tax Expense	0.11	0.06	0.19	0.08	0.03	-
Earnings From Continuing Operations	-20.6	-30.22	-6.72	-19.6	-13.55	-9.28
Earnings From Discontinued Operations	-	-	-	-	-	0.08
Net Income	-20.6	-30.22	-6.72	-19.6	-13.55	-9.2
Net Income to Common	-20.6	-30.22	-6.72	-19.6	-13.55	-9.2
Shares Outstanding (Basic)	11	10	9	5	4	4
Shares Outstanding (Diluted)	11	10	9	5	4	4
Shares Change (YoY)	13.58%	10.50%	80.73%	28.13%	0.24%	-
EPS (Basic)	-1.90	-3.03	-0.75	-3.93	-3.48	-2.37
EPS (Diluted)	-1.90	-3.03	-0.75	-3.93	-3.48	-2.37
Free Cash Flow	-18.6	-19.9	-16.93	-12.44	-9.41	-7.82
Free Cash Flow Per Share	-1.71	-2.00	-1.88	-2.49	-2.42	-2.01
Gross Margin	18.53%	13.03%	19.15%	49.69%	36.91%	34.67%
Operating Margin	-112.59%	-95.94%	-82.95%	-28.91%	-47.22%	-40.62%
Profit Margin	-98.43%	-149.46%	-35.94%	-73.97%	-57.03%	-42.25%
Free Cash Flow Margin	-88.86%	-98.39%	-90.60%	-46.95%	-39.58%	-35.92%
EBITDA	-22.66	-18.58	-14.76	-6.39	-9.98	-7.75
EBITDA Margin	-108.27%	-91.88%	-79.01%	-24.11%	-42.01%	-35.61%
D&A For EBITDA	0.9	0.82	0.74	1.27	1.24	1.09
EBIT	-23.57	-19.4	-15.5	-7.66	-11.22	-8.84
EBIT Margin	-112.59%	-95.94%	-82.95%	-28.91%	-47.22%	-40.62%
Revenue as Reported	20.22	20.22	18.69	26.5	23.76	21.76

Updated Nov 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q